"The Board of Directors of the Company has duly approved and ratified the Asset Purchase Agreement, effective as of December 31, 2025 (the “Asset Purchase Agreement”), by and between the Company and ERApeutics, LLC, pursuant to which the Company acquired substantially all of the assets associated with the EVERMIND™ business." BFCH